Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Elevance Health, Inc. (ELV) EV/Sales

As of 25 September 2026, Elevance Health, Inc. (ELV) trades at a EV/Sales of 0.4×. Over the past ten years it has ranged from 0.3× (November 2016) to 0.8× (February 2019); the current reading is higher than 20% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 0.4× (19.10%)
FY2024 0.5× (22.12%)
FY2023 0.6× (15.75%)
FY2022 0.7× (5.14%)
FY2021 0.7× 29.34%
FY2020 0.6× (15.81%)
FY2019 0.7× (0.67%)
FY2018 0.7× 17.07%
FY2017 0.6× 70.44%
FY2016 0.3× (11.81%)

Quarterly

Period EV/Sales Change
Jun 2026 0.4× 32.16%
Mar 2026 0.3× (21.92%)
Dec 2025 0.4× 7.15%
Sep 2025 0.3× (20.24%)
42 more quarters

Against its own ten years

Low 0.3× High 0.8×
Ten-year median 0.6×
Current reading's percentile 20

EV/Sales against peers

Company EV/Sales
CNC Centene Corporation compare 0.1×
MOH Molina Healthcare, Inc compare 0.1×
HUM Humana Inc. compare 0.3×
CI Cigna Group compare 0.3×
OSCR Oscar Health, Inc. compare 0.3×
CVS CVS Health Corporation compare 0.4×
ELV Elevance Health, Inc. 0.4×
UNH UnitedHealth Group Incorporated compare 0.8×
CLOV Clover Health Investments, Corp. compare 0.9×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ELV